Whitener Capital Management Inc. Purchases 500 Shares of Baxter International Inc. (NYSE:BAX)


Share on StockTwits

Whitener Capital Management Inc. boosted its position in Baxter International Inc. (NYSE:BAX) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,292 shares of the medical instruments supplier’s stock after acquiring an additional 500 shares during the period. Whitener Capital Management Inc.’s holdings in Baxter International were worth $1,387,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Caisse DE Depot ET Placement DU Quebec grew its holdings in Baxter International by 3.5% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,874,269 shares of the medical instruments supplier’s stock worth $633,249,000 after acquiring an additional 266,100 shares during the last quarter. California Public Employees Retirement System lifted its position in shares of Baxter International by 1.6% in the 4th quarter. California Public Employees Retirement System now owns 4,102,676 shares of the medical instruments supplier’s stock worth $329,199,000 after purchasing an additional 62,795 shares during the period. UBS Asset Management Americas Inc. lifted its position in shares of Baxter International by 1.3% in the 3rd quarter. UBS Asset Management Americas Inc. now owns 2,356,187 shares of the medical instruments supplier’s stock worth $189,485,000 after purchasing an additional 30,347 shares during the period. New York State Common Retirement Fund lifted its position in shares of Baxter International by 1.6% in the 3rd quarter. New York State Common Retirement Fund now owns 2,103,977 shares of the medical instruments supplier’s stock worth $169,202,000 after purchasing an additional 33,880 shares during the period. Finally, Neuberger Berman Group LLC lifted its position in shares of Baxter International by 2.0% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,056,874 shares of the medical instruments supplier’s stock worth $84,962,000 after purchasing an additional 20,228 shares during the period. 82.89% of the stock is currently owned by institutional investors and hedge funds.

BAX has been the subject of several research analyst reports. Credit Suisse Group dropped their target price on shares of Baxter International from $99.00 to $95.00 and set an “outperform” rating for the company in a research report on Friday, February 5th. UBS Group cut shares of Baxter International from a “buy” rating to a “neutral” rating and lowered their price target for the company from $95.00 to $85.00 in a research report on Wednesday, January 6th. Raymond James lowered their price target on shares of Baxter International from $88.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, February 5th. Stifel Nicolaus lowered their price target on shares of Baxter International from $90.00 to $88.00 and set a “buy” rating for the company in a research report on Monday, November 2nd. Finally, Morgan Stanley lifted their price target on shares of Baxter International from $84.00 to $90.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 15th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $92.31.

Shares of BAX stock traded up $1.31 during trading hours on Thursday, reaching $78.99. The company had a trading volume of 35,327 shares, compared to its average volume of 2,835,432. The business has a fifty day moving average price of $79.25 and a 200-day moving average price of $80.22. Baxter International Inc. has a one year low of $69.10 and a one year high of $95.19. The firm has a market cap of $39.90 billion, a PE ratio of 44.14, a price-to-earnings-growth ratio of 2.53 and a beta of 0.65. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.06 and a current ratio of 2.64.

Baxter International (NYSE:BAX) last announced its quarterly earnings results on Wednesday, February 3rd. The medical instruments supplier reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04. Baxter International had a net margin of 7.90% and a return on equity of 20.81%. The firm had revenue of $3.18 billion during the quarter, compared to analyst estimates of $3.10 billion. During the same period in the previous year, the business posted $0.97 earnings per share. The business’s revenue for the quarter was up 4.7% on a year-over-year basis. Equities research analysts forecast that Baxter International Inc. will post 3.04 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 1st. Stockholders of record on Friday, February 26th will be paid a $0.245 dividend. The ex-dividend date is Thursday, February 25th. This represents a $0.98 dividend on an annualized basis and a dividend yield of 1.24%. Baxter International’s dividend payout ratio is presently 29.61%.

Baxter International Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Featured Article: What is the FTSE 100 index?

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.